The Journal of Nuclear Medicine Vol. 7 No. 3 209-218
© 1966 by Society of Nuclear Medicine
Mercury-197 and Mercury-203 Chlormerodrin for Evaluation of Brain Lesions Using a Rectilinear Scanner and Scintillation Camera2
Merle K. Loken, Ph.D., M.D.1,
Luther O. Wigdahl, M.D.,
J. Michael Gilson, M.D. and
Edward V. Staab, M.D.
Minneapolis, Minnesota
ABSTRACT
- 1) The results were presented of 432 patients conventionally scanned with 197Hg-chlormerodrin were studied in a retrospective blind study.
- 2) Forty-two patients in which 203Hg-chlormerodrin and 197Hg-chlormerodrin was used as the radioactive agent were studied, and no significant difference in percentage of positive examinations was found.
- 3) 107 patients, after receiving 197Hg-chlormerodrin, were studied using both the scintillation camera and rectilinear scanning techniques. A comparison of the two methods used consecutively revealed that each gave information verifying the other and of essentially equal accuracy.
FOOTNOTES
2 Supported in part by funds from the American Cancer Society (Institutional Grant) and the Graduate School, University of Minnesota.
1 From the University of Minnesota and Veterans Administration Hospitals, Minneapolis.
Copyright © 1966 by the Society of Nuclear Medicine.